Montelukast is the generic version of the brand-name ... their doctor may prescribe the chewable tablet in a dose lower than 10 mg. In this case, they may have a higher risk of side effects ...

Montelukast (Jotair (10 mg)) is a leukotriene receptor antagonists (LTRAs), prescribed for asthma. It works by blocking a substance called leukotriene. The information provided on this page is ...

Reddy’s Laboratories (RDY) has launched Montelukast ... United States Food & Drug Administration of Dr. Reddy’s ANDA. The SINGULAIR® tablets and Chewable tablets brand had U.S. sales of ...

for its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Tablets, 10 mg, the generic version of Merck's Singulair® Tablets. Mylan also received final FDA approval for its ANDA for ...

The U.S. Food and Drug Administration is warning consumers ... Recalled lots of montelukast sodium tablets, USP 10mg have the following information: Label: Montelukast Sodium Tablets 10 mg 30 ...

Montelukast was originally developed and sold by Merck, under the brand name Singulair. Approved by the FDA in 1998, the anti-inflammatory drug—taken an once-daily pill—became a mainstay ...

Dr Seymour: On September 23, 2014, montelukast [Singulair] was discussed at the PAC meeting as part of a routine pediatric safety review conducted after a drug has new pediatric labeling.

It used to be that generic drugs had one common co-pay and name-brand drugs another ... s website and at its drug list, also known as a formulary, revealed that Montelukast is listed as a Tier ...

Montelukast (Romilast (10 mg)) is a leukotriene receptor antagonists (LTRAs), prescribed for asthma. It works by blocking a substance called leukotriene. The information provided on this page is ...